Healthcare >> CEO Interviews >> May 8, 2002
CHRISTOPHER S. HENNEY joined Dendreon Corporation as Chief Executive
Officer in May 1995. In 1989, Dr. Henney co-founded ICOS Corporation
where from 1989 to 1995, he served as Executive Vice President,
Scientific Director and Director. In 1981, Dr. Henney co-founded Immunex
Corporation where from 1981 to 1989, he held various positions,
including Director, Vice Chairman and Scientific Director. Prior to
founding Immunex, Dr. Henney was an Academic Immunologist, serving as
Professor at Johns Hopkins University and then the University of
Washington where he also headed the immunology program at the Fred
Hutchinson Cancer Research Center. Dr. Henney received a BSc with
Honors, a PhD in Experimental Pathology and a DSc for his contributions
to Immunology from the University of Birmingham, England. Profile
TWST: What is the current agenda at Dendreon?Dr. Henney: Dendreon is an immunology company that is developing
a series of novel therapeutic vaccines and other immunological
products,